FDA Approves Expanded Use of Eculizumab (Soliris) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
The American Journal of Managed Care3d
Myasthenia Gravis Care Overlooks Speech and Swallowing Dysfunction
Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...
MedPage Today on MSN5d
Myasthenia Gravis Exacerbations
Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...